Rapid Dose Therapeutics Corp. (CSE:DOSE)

Canada flag Canada · Delayed Price · Currency is CAD
0.150
+0.015 (11.11%)
At close: Feb 27, 2026
-21.05%
Market Cap 20.28M
Revenue (ttm) 2.78M
Net Income (ttm) -4.37M
Shares Out 135.18M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 16,000
Average Volume 65,993
Open 0.150
Previous Close 0.135
Day's Range 0.150 - 0.150
52-Week Range 0.125 - 0.240
Beta -0.90
RSI 52.25
Earnings Date Jun 26, 2026

About Rapid Dose Therapeutics

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release into the blood stream a list of pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also engages in the research, production, provis... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Mark Upsdell
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol DOSE
Full Company Profile

Financial Performance

In fiscal year 2025, Rapid Dose Therapeutics's revenue was 2.09 million, an increase of 104.34% compared to the previous year's 1.02 million. Losses were -5.40 million, 25.5% more than in 2024.

Financial Statements

News

There is no news available yet.